#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Transitional cell carcinoma Cervix carcinoma recurrent Thymic carcinoma Partial lipodystrophy Hereditary hypophosphataemic rickets Glycogen storage disease type II Squamous cell carcinoma of head and neck Oesophageal adenocarcinoma Cystic fibrosis gastrointestinal disease Astrocytoma malignant Hypochromic anaemia Familial haemophagocytic lymphohistiocytosis Hyperinsulinism Friedreich's ataxia More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic X-linked lymphoproliferative syndrome – Life with Disease Rhabdoid tumour – Basic Information Haemophilia B without inhibitors – Basic Information Nephrotic syndrome – Diagnostics Retinoblastoma – Trials in Disease Pemphigoid – Basic Information Angelman’s syndrome Adrenogenital syndrome – Treatment Fragile X syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zipalertinib SOFTISAN 378 Atomoxetine Hydrochloride Mezigdomide Triamcinolone Saxagliptin Treprostinil Sodium Alnuctamab Damoctocog Alfa Pegol Etifoxine Hydrochloride Triamcinolone Hexacetonide Poa Pratensis Pollen Extract INF904 Zalunfiban Radotinib Dihydrochloride Anhydrous Glucose Bp Rbl027.2 Vinflunine MORPHINE Avutometinib More therapies…

    Learn about Your Condition

    Renal impairment Rabies Rectal cancer Malignant melanoma of eyelid Renal cancer metastatic Angiopathy Anal cancer stage II Chronic hepatitis C Rosai-Dorfman syndrome Sinusitis bacterial Addison's disease Endotracheal intubation Hidradenitis Dementia Alzheimer's type Ligament operation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Medical device site joint infection

  • Study on the Impact of Cefepime, Piperacillin-Tazobactam, and Ceftobiprole on Gut Health in Patients with Bone and Joint Infections on Implants

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Cefepime
    • Daptomycin
    • Piperacillin
    France

  • Study on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fracture infection
    • Medical device site joint infection
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Rifampicin
    Belgium

  • Study on the Use of Gallium Citrate Ga-68 for Diagnosing Chronic Infections in Artificial Hip and Knee Joints

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Gallium Citrate Ga-68
    France

  • Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Saline
    • Vancomycin
    Sweden

  • Study on the Effects of Rifampicin, Amoxicillin, and Moxifloxacin in Treating Prosthetic Joint Infections Caused by Cutibacterium acnes for Affected Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Doxycycline
    • Rifampicin
    • Amoxicillin
    France

  • Study on Antibiotic Treatment for Hip and Knee Joint Infections Using Linezolid, Fusidic Acid, and Rifampicin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Fusidic Acid
    • Ofloxacin Hydrochloride
    • Bromhexine Hydrochloride
    Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!